Back
Bicara Therapeutics Vs. Impinj Industry Stock Comparison
Buy
60
BCAX
Bicara Therapeutics
Last Price:
$14.77
Seasonality Move:
--
Buy
55
PI
Impinj
Last Price:
$90.31
Seasonality Move:
37.66%
Buy
60
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $15.63. The Score for BCAX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $15.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PI Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 68.06 | Buy |
Chaikin Money Flow: | 220876 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.75 - 13.97) | Buy |
Bollinger Bands (100): | (11.47 - 17.39) | Buy |
PI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.18 | Sell |
Relative Strength Index (14 RSI): | 59.09 | Buy |
Chaikin Money Flow: | 295201 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (68.22 - 89.98) | Buy |
Bollinger Bands (100): | (83.35 - 153.71) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.05 | Buy |
20-day SMA: | 12.14 | Buy |
50-day SMA: | 12.87 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.51 | Buy |
20-day EMA: | 12.68 | Buy |
50-day EMA: | 12.95 | Buy |
200-day EMA: | 11.44 | Buy |
PI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.49 | Buy |
20-day SMA: | 76.17 | Buy |
50-day SMA: | 87.87 | Buy |
200-day SMA: | 151.07 | Sell |
8-day EMA: | 75.9 | Buy |
20-day EMA: | 77.23 | Buy |
50-day EMA: | 90.85 | Sell |
200-day EMA: | 129.05 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.
Impinj Earnings Growth & PI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.54 per share, a decrease this year of $0.39 per share, and an increase next year of $0.99 per share.
Bicara Therapeutics Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Impinj Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |